This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2010 May 27;115(21):4152-3.

doi: 10.1182/blood-2010-02-271338.

Refining "total therapy" for myeloma

Joan Bladé¹, Laura Rosiñol

Affiliations

PMID: 20508167
DOI: 10.1182/blood-2010-02-271338

Free article

Comment

Refining "total therapy" for myeloma

Joan Bladé et al. Blood. 2010.

Free article

. 2010 May 27;115(21):4152-3.

doi: 10.1182/blood-2010-02-271338.

Authors

Joan Bladé¹, Laura Rosiñol

Affiliation

¹ Hospital Clinic, IDIBAPS, Barcelona.

PMID: 20508167
DOI: 10.1182/blood-2010-02-271338

No abstract available

PubMed Disclaimer

Comment on

Superior results of Total Therapy 3 (2003-33) in gene expression profiling-defined low-risk multiple myeloma confirmed in subsequent trial 2006-66 with VRD maintenance.
Nair B, van Rhee F, Shaughnessy JD Jr, Anaissie E, Szymonifka J, Hoering A, Alsayed Y, Waheed S, Crowley J, Barlogie B. Nair B, et al. Blood. 2010 May 27;115(21):4168-73. doi: 10.1182/blood-2009-11-255620. Epub 2010 Feb 2. Blood. 2010. PMID: 20124509 Free PMC article. Clinical Trial.

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
- Silverchair Information Systems